Effective antioxidant therapy for the management of arrhythmia

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 7, 2011, Pages 797-800

  Sovari, Ali A ^a   Bonini, Marcelo G ^a   Dudley, Samuel C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

antiarrhythmic; arrhythmia; atrial fibrillation; oxidative stress; sudden cardiac death

Indexed keywords

ANTIOXIDANT; APOCYNIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; HYDROGEN PEROXIDE; HYDROXYL RADICAL; N(G) NITROARGININE METHYL ESTER; PEROXYNITRITE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; BIOSYNTHESIS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CARDIOVASCULAR RISK; DRUG EFFICACY; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART FAILURE; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SODIUM CURRENT; SUDDEN DEATH;

ANTIOXIDANTS; ARRHYTHMIAS, CARDIAC; CALCIUM; DRUG DELIVERY SYSTEMS; HUMANS; REACTIVE OXYGEN SPECIES; SODIUM CHANNELS;

EID: 79961196063     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.85     Document Type: Review

References (35)

1. Chugh SS, Reinier K, Teodorescu C et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog. Cardiovasc. Dis. 51, 213-228 (2008).
2. Ide T, Tsutsui H, Kinugawa S et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ. Res. 86, 152-157 (2000). (Pubitemid 30086175)
3. Sam F, Kerstetter DL, Pimental DR et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J. Card. Fail. 11, 473-480 (2005).
4. Sovari AA, Dudley SC. Oxidative stress and atrial fibrillation. In:Studies on Cardiovascular Disorders (1st Edition). Sauer H, Ajay MS, Laurindo FR (Eds).Humana Press, NY, USA, 373-389 (2010).
5. Song Y, Cook NR, Albert CM, Van DM, Manson JE. Effects of vitamins C and E and b-carotene on the risk of Type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am. J. Clin. Nutr. 90, 429-437 (2009).
6. Sesso HD, Buring JE, Christen WG et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians Health Study II randomized controlled trial. JAMA 300, 2123-2133 (2008).
7. Wosniak J Jr, Santos CX, Kowaltowski AJ, Laurindo FR. Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. Antioxid. Redox Signal. 11, 1265-1278 (2009).
8. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl Acad. Sci. USA 107, 15565-15570 (2010).
9. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342-344 (2002). (Pubitemid 34852301)
10. Freeman BA, White CR, Gutierrez H, Paler-Martinez A, Tarpey MM, Rubbo H. Oxygen radical-nitric oxide reactions in vascular diseases. Adv. Pharmacol. 34, 45-69 (1995).
11. Beresewicz A, Horackova M. Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: possible ionic mechanisms. J. Mol. Cell. Cardiol. 23, 899-918 (1991).
12. Morita N, Sovari AA, Xie Y et al. Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 297, H1594-H1605 (2009).
13. Shang LL, Sanyal S, Pfahnl AE et al. NF-kB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am. J. Physiol. Cell Physiol. 294, C372-C379 (2008).
14. Morita N, Lee JH, Xie Y, Sovari A, Qu Z, Weiss JN, Karagueuzian HS. Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. J. Am. Coll. Cardiol. 57, 366-375 (2011).
15. Liu M, Liu H, Dudley SC Jr. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ. Res. 107, 967-974 (2010).
16. Thomas GP, Sims SM, Cook MA, Karmazyn M. Hydrogen peroxide-induced stimulation of l-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation. J. Pharmacol. Exp. Ther. 286, 1208-1214 (1998). (Pubitemid 29135531)
17. Anzai K, Ogawa K, Kuniyasu A, Ozawa T, Yamamoto H, Nakayama H. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem. Biophys. Res. Commun. 249, 938-942 (1998). (Pubitemid 28441942)
18. 2+-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Radic. Biol. Med. 22, 37-47 (1997). (Pubitemid 26399309)
19. 2+/calmodulin- dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84, 713-721 (1999). (Pubitemid 29157339)
20. Erickson JR, Joiner ML, Guan X et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462-474 (2008). (Pubitemid 351608692)
21. Witcher DR, Kovacs RJ, Schulman H, Cefali DC, Jones LR. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J. Biol. Chem. 266, 11144-11152 (1991). (Pubitemid 21906924)
22. 2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes. Cardiovasc. Res. 85, 454-463 (2010).
23. 2+ current facilitation: a modeling study. Biophys. J. 96, 1770-1785 (2009).
24. Gros DB, Jongsma HJ. Connexins in mammalian heart function. Bioessays 18, 719-730 (1996). (Pubitemid 26351964)
25. Gutstein DE, Morley GE, Tamaddon H et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ. Res. 88, 333-339 (2001). (Pubitemid 32173758)
26. Kieken F, Mutsaers N, dolmatova E et al. Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ. Res. 104, 1103-1112 (2009).
27. Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Tada M, Hori M. Functional role of c-Src in gap junctions of the cardiomyopathic heart. Circ. Res. 85, 672-681 (1999). (Pubitemid 29480807)
28. Aikawa R, Komuro I, Yamazaki T et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100, 1813-1821 (1997). (Pubitemid 27431340)
29. Seshiah PN, Kereiakes DJ, Vasudevan SS et al. Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact. Circulation 105, 174-180 (2002). (Pubitemid 34084315)
30. Kasi VS, Xiao HD, Shang LL et al. Cardiac-restricted angiotensin- converting enzyme overexpression causes conduction defects and connexin dysregulation. Am. J. Physiol. Heart Circ. Physiol. 293, H182-H192 (2007). (Pubitemid 47105073)
31. Sovari AA, Jiao Z, Dolmatova E et al. c-Src tyrosine kinase is a potential therapeutic target to prevent angiotensin-II mediated connexin43 remodeling and ventricular arrhythmia. Circulation 122 (2010) (Abstract).
32. Sovari AA, Iravanian S, Mitchell D et al. Mitochondria-targeted antioxidant, mito-tempo, prevents angiotensin ii mediated connexin43 remodeling and sudden cardiac death. J. Investig. Med. 59, 692-730 (2011) (Abstract).
33. Kukushkina OI, Fedotkina LK, Balashov VP, Balykova LA, Sosunov AA. [Effect of NO-synthetase inhibitor L-NAME on occlusive and reperfusion arrhythmias in cats]. Bull. Eksp. Biol. Med. 127, 509-511 (1999).
34. O'Rourke B, Cortassa S, Aon MA. Mitochondrial ion channels: gatekeepers of life and death. Physiology (Bethesda) 20, 303-315 (2005). (Pubitemid 41457396)
35. Carnes CA, Chung MK, Nakayama T et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 89, E32-E38 (2001).